Hematology

Trials, guidelines and clinical evidence across Hematology.

Bone Marrow Reporter Strategy Identifies Nonmigratory Stem Cell Subset

A new reporter strategy identified nonmigratory hematopoietic stem cells in a dynamic bone marrow niche, refining how stem cell residency is viewed.

By Dr. Revathy Mohan V.R., MBBS · Oct 26, 2026 · 5 min read

Hematology·ARD

Therapeutic Apheresis Guidelines Update Expands to 93 Fact Sheets

ASFA’s Tenth Special Issue updates therapeutic apheresis guidance with 93 fact sheets and 183 graded indications across human…

Oct 25, 2026

Hematology·ARD

Therapeutic Apheresis Guidelines Updated in ASFA Tenth Edition

ASFA’s Tenth Special Issue updates evidence-based therapeutic apheresis guidance, spanning 93 fact sheets, 183 graded indications, and new…

Oct 24, 2026

Hematology·DailyMed

Eltrombopag label warns of liver injury, clots, and cataracts

Eltrombopag’s Medication Guide warns of liver injury, thrombosis, cataracts, and dosing interactions across ITP, hepatitis C, and aplastic…

Oct 24, 2026

Hematology·JCI

SEPTIN6 mutations drive stem cell senescence in congenital neutropenia

Patient-derived SEPTIN6 mutations were linked to hematopoietic stem cell senescence, offering a mechanistic explanation for congenital neutropenia and…

Oct 24, 2026

Hematology·JCO

ASFA Tenth Edition updates therapeutic apheresis indications across 93 fact sheets

ASFA’s 10th special issue updates evidence grading for therapeutic apheresis, spanning 93 fact sheets and 183 graded indications…

Oct 24, 2026

Hematology·Blood

CXCR4 and Treg Migration After HSCT May Balance GVL and GVHD

CXCR4-linked migration differences in peripheral Tregs and Tcons may help preserve graft-versus-leukemia effects while limiting GVHD after HSCT.

Oct 23, 2026

Hematology·DailyMed

Eltrombopag label update expands dosing and safety guidance

DailyMed’s updated eltrombopag label reinforces boxed liver warnings, dosing by indication, and thrombosis risk across ITP, hepatitis C,…

Oct 23, 2026

Hematology·JCO

DOAC Therapy in Complex Patients Faces Renal, Cancer, and APS Limits

A clinical review examines where DOACs fit, and where caution is still warranted, across renal disease, obesity, cancer,…

Oct 23, 2026

Hematology·JCO

ASFA therapeutic apheresis guidelines expand to 93 fact sheets

ASFA’s Tenth Special Issue updates therapeutic apheresis indications with evidence grading across 93 fact sheets and 183 categorized…

Oct 23, 2026

Hematology

Trials, guidelines and clinical evidence across Hematology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.